Bilateral TKA is proven to be safe in a select group of patients. Patients with symptomatic bilateral knee arthritis who are not candidates for simultaneous bilateral TKA are subjected to staged surgery. The main objective of this study is to determine the safe window when second TKA can be performed in patients requiring bilateral TKA Retrospective study includes bilateral TKA cases performed in a single institution between 2000–2018. A cohort of simultaneous bilateral TKA (n=2728) was compared to cohort of staged bilateral TKA (n=1660). Outcomes in terms of complications, reoperation, 30 days readmission and cumulative revision rates were compared between the two groups using both non-adjusted and adjusted models.Introduction
Methods
Recovery after total knee arthroplasty (TKA) may take longer than patients expect. Furthermore, there are a subset of patients who still experience pain and dissatisfaction despite normal physical examination, radiographs, and laboratory analysis. Corticosteroid injection (CSI) is commonly used nonsurgical treatment for painful knee arthritis. However, the efficacy of CSI in patients with a painful TKA remains unknown. A retrospective charge review was performed to identify a cohort of patients who had a primary TKA performed between 2015 and 2016 and later received a CSI. All TKAs and CSIs were performed by a fellowship-trained arthroplasty surgeon. Patients receiving a CSI underwent a clinical exam, laboratory analysis to rule out infection, and radiographic evaluation prior to injection. Patient variables were recorded and a survey assessed the efficacy of the injection. The survey response rate was 63.6%.Introduction
Methods
